Francois Audenet
Overview
Explore the profile of Francois Audenet including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
112
Citations
1035
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Proye P, Gondran-Tellier B, Michel F, Bensalah K, Bigot P, Audenet F, et al.
Eur Urol Open Sci
. 2025 Mar;
73:60-67.
PMID: 40034716
Background And Objective: A renal mass biopsy (RMB) is not systematically recommended before surgical excision of a renal mass, although it has demonstrated elevated accuracy in determining renal masses with...
2.
Houede N, Chevallier T, Audenet F, Thibault C, Neuzillet Y, Abraham C, et al.
J Clin Oncol
. 2025 Feb;
:JCO2500179.
PMID: 39951246
Purpose: After radical nephroureterectomy (RNU) for upper tract urothelial carcinoma (UTUC), prognosis is poor for high-risk patients. This study evaluated safety and efficacy of neoadjuvant chemotherapy (cisplatin or carboplatin +...
3.
Margue G, Klein C, Parier B, Albiges L, Pignot G, Gravis G, et al.
Urol Oncol
. 2024 Nov;
PMID: 39603878
Background: Complete responses to immunotherapy in metastatic kidney cancer have led to a renewed interest in primary-site surgery. The prolonged survival of these patients has prompted consideration for nephron-sparing surgery...
4.
Roumiguie M, Seisen T, Masson-Lecomte A, Prost D, Allory Y, Xylinas E, et al.
Fr J Urol
. 2024 Nov;
34(12):102722.
PMID: 39581669
Introduction: The purpose of this study was to propose an update of the French guidelines from the national committee ccAFU on upper tract urothelial carcinomas (UTUC). Methods: A systematic Medline...
5.
Roumiguie M, Leon P, Xylinas E, Allory Y, Audenet F, Bajeot A, et al.
Fr J Urol
. 2024 Nov;
34(12):102742.
PMID: 39581667
Objective: To update the CCAFU recommendations for the management of non-muscle invasive bladder cancer (NMIBC). Methods: A systematic review (Medline) of the literature from 20222024 was performed, taking into account...
6.
Roumiguie M, Marcq G, Neuzillet Y, Bajeot A, Allory Y, Sargos P, et al.
Fr J Urol
. 2024 Nov;
34(12):102741.
PMID: 39581664
Objective: To update the CCAFU recommendations for the management of muscle-invasive bladder cancer (MIBC). Methods: A systematic review (Medline) of the literature from 2022 to 2024 was carried out, taking...
7.
Ferragu M, Bernhard J, Fontenil A, Guillotreau J, Panthier F, Branger N, et al.
World J Urol
. 2024 Nov;
42(1):642.
PMID: 39570380
Introduction: The rising incidence of renal cell carcinoma (RCC) is a significant concern in cancer research. This study analyses the characteristics of RCC patients based on their socio-professional category and...
8.
Hmila S, Panthier F, Dariane C, Le Houerou T, Rischard J, Audenet F, et al.
Fr J Urol
. 2024 Oct;
35(1):102801.
PMID: 39461726
The synoptic operative report (SOR) is a model with several advantages but still not enough adopted. We studied the performance of a SOR template (FileMaker Pro®, FMP) versus the usual...
9.
Barthe F, Bentellis I, Bernhard J, Bensalah K, Champy C, Bruyere F, et al.
Fr J Urol
. 2024 Oct;
35(1):102753.
PMID: 39369793
Introduction: The average hospital length of stay after robotic-assisted partial nephrectomy (RAPN) is 3 days, with a current trend towards outpatient cases, although no population has been identified. The main...
10.
Martini A, Bernhard J, Falagario U, Herman G, Geshkovska A, Khene Z, et al.
Minerva Urol Nephrol
. 2024 Sep;
76(5):578-587.
PMID: 39320248
Background: In 2021, the EAU Guidelines implemented a novel, expert opinion-based follow-up scheme, with a three-risk-category system for clear cell (cc) and non-cc renal cell carcinoma (non-ccRCC) after surgery with...